Lite Strategy, Inc.(LITS)

Biotechnology · San Diego, CA

$1.42+0.02 (+1.43%)

Delayed quote: Oct 6, 2026, 1:27 PM EDT

Lite Strategy (LITS) PE Ratio: History & Chart | TGMCharts

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T17:37:10.988Z.

Stored calculation inputs

Calculation as of: 2026-10-06T17:37:10.988Z.

Quote observation: 2026-10-06T17:35:06.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 1.405
Unrounded diluted TTM EPS · period ending 2026-06-30: -9.11

FMP input reference: 0dc40ddd6b0c815ea8fb06d6c0f10798674f4babd9a38c246e46e89e51900236

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

LITS PE Ratio Metrics

PE RATIO

N/A

LITS Competitors' PE Ratio

LITS

Lite Strategy, Inc.

Current

Market Cap

$47.81M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

POCI

Precision Optics Corporation, Inc.

vs LITS

Market Cap

$48.16M

PE Ratio

N/A

TTM Avg

43.98

3Y Avg

82.17

5Y Avg

82.17

TELA

TELA Bio, Inc.

vs LITS

Market Cap

$49.21M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs LITS

Market Cap

$49.41M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBOT

Microbot Medical Inc.

vs LITS

Market Cap

$49.44M

PE Ratio

N/A

TTM Avg

6.87

3Y Avg

6.87

5Y Avg

6.87

INMB

INmune Bio, Inc.

vs LITS

Market Cap

$49.45M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SRTS

Sensus Healthcare, Inc.

vs LITS

Market Cap

$49.55M

PE Ratio

N/A

TTM Avg

20.76

3Y Avg

21.54

5Y Avg

20.97

DWTX

Dogwood Therapeutics, Inc.

vs LITS

Market Cap

$49.77M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELU

Celularity Inc.

vs LITS

Market Cap

$49.64M

PE Ratio

N/A

TTM Avg

11.46

3Y Avg

11.53

5Y Avg

11.53

TIL

Instil Bio, Inc.

vs LITS

Market Cap

$46.25M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Lite Strategy, Inc. (LITS)	$47.81M	N/A	N/A	N/A	N/A
Precision Optics Corporation, Inc. (POCI)vs ›	$48.16M	N/A	43.98	82.17	82.17
TELA Bio, Inc. (TELA)vs ›	$49.21M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$49.41M	N/A	N/A	N/A	N/A
Microbot Medical Inc. (MBOT)vs ›	$49.44M	N/A	6.87	6.87	6.87
INmune Bio, Inc. (INMB)vs ›	$49.45M	N/A	N/A	N/A	N/A
Sensus Healthcare, Inc. (SRTS)vs ›	$49.55M	N/A	20.76	21.54	20.97
Dogwood Therapeutics, Inc. (DWTX)vs ›	$49.77M	N/A	N/A	N/A	N/A
Celularity Inc. (CELU)vs ›	$49.64M	N/A	11.46	11.53	11.53
Instil Bio, Inc. (TIL)vs ›	$46.25M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$1.41

Forward EPS (Est.)

$-1.56

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

LITS PE Ratio Metrics

LITS Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics